Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: a Biobadaderm cohort analysis

dc.contributor.authorBaniandrés-Rodríguez, Ofelia
dc.contributor.authorFerran Farrés, Marta
dc.contributor.authorGarcía-Doval, Ignacio
dc.contributor.authorBiobadaderm Study Group
dc.date.accessioned2022-02-22T08:03:40Z
dc.date.available2022-02-22T08:03:40Z
dc.date.issued2021
dc.format.mimetypeapplication/pdf
dc.identifier.citationBaniandrés-Rodríguez O, Vilar-Alejo J, Rivera R, Carrascosa JM, Daudén E, Herrera-Acosta E, et al. Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: a Biobadaderm cohort analysis. J Am Acad Dermatol. 2021 Feb; 84(2): 513-7. DOI: 10.1016/j.jaad.2020.10.046
dc.identifier.doihttp://dx.doi.org/10.1016/j.jaad.2020.10.046
dc.identifier.issn0190-9622
dc.identifier.urihttp://hdl.handle.net/10230/52538
dc.language.isoeng
dc.publisherElsevier
dc.rights© Elsevier http://dx.doi.org/10.1016/j.jaad.2020.10.046
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.subject.otherCOVID-19 (Malaltia)
dc.subject.otherPsoriasi -- Tractament
dc.titleIncidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: a Biobadaderm cohort analysis
dc.typeinfo:eu-repo/semantics/article
dc.type.versioninfo:eu-repo/semantics/acceptedVersion

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
beniandres-jaa-inci.pdf
Size:
606.98 KB
Format:
Adobe Portable Document Format